HRA Pharma - Company & Market Research Reports

HRA Pharma is a consumer healthcare company that develops treatments in the areas of women’s health and endocrinology. Founded in 1998, HRA is leading the European Emergency Hormonal Contraception Market. The company's women’s health products include ellaOne, Clareva Gel, Cicatridine, Lysodren and Mona Lisa. HRA has 8 products in their portfolio and are marketed in 90 countries worldwide. It has 7 European subsidiaries covering 11 countries, with over 180 employees. It’s headquartered in Paris, France.

From
From
From
Ovarian Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Ovarian Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 2412 Pages
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator
adroll